4//SEC Filing
Wechsler Daniel Mark 4
Accession 0001209191-17-059614
CIK 0001461993other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 4:43 PM ET
Size
7.8 KB
Accession
0001209191-17-059614
Insider Transaction Report
Form 4
Wechsler Daniel Mark
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2017-11-03+550,981→ 550,981 totalExercise: $11.63Exp: 2027-11-03→ Common Stock (550,981 underlying) - Award
Restricted Stock Units
2017-11-03+183,661→ 183,661 totalExercise: $0.00→ Common Stock (183,661 underlying)
Footnotes (1)
- [F1]The award vests 25% on November 3, 2018 and the remainder will vest in equal monthly installments during the 3 years following the initial vesting date, subject to the Reporting Person's continued employment with the Issuer.
Documents
Issuer
MELINTA THERAPEUTICS, INC. /NEW/
CIK 0001461993
Entity typeother
Related Parties
1- filerCIK 0001582285
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 4:43 PM ET
- Size
- 7.8 KB